2Seventy Bio Inc
NASDAQ:TSVT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
2Seventy Bio Inc
NASDAQ:TSVT
|
US |
|
G
|
GCCP Resources Ltd
SGX:41T
|
MY |
|
4DS Memory Ltd
ASX:4DS
|
AU |
|
H
|
Helix Resources Ltd
ASX:HLX
|
AU |
|
R
|
Resource Base Ltd
ASX:RBX
|
AU |
|
Applied DNA Sciences Inc
NASDAQ:APDN
|
US |
|
S
|
SHF Holdings Inc
NASDAQ:SHFS
|
US |
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TSVT's stock price target?
Not Available
TSVT doesn't have any price targets made by Wall Street professionals.
What is 2Seventy Bio Inc's Revenue forecast?
Projected CAGR
29%
For the last 5 years the
compound annual growth rate for
2Seventy Bio Inc's revenue is
-3%.
The projected
CAGR
for the next 3 years is
29%.